Led by $90m venture financing of Hyperfine Research, total medical devices industry cross border venture financing deals worth $715.46m were announced in North America in Q1 2021, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 15% over the previous quarter and a drop of 6.9% when compared with the last four-quarter average of $768.63m.

North America held a 60.63% share of the global medical devices industry cross border venture financing deal value that totalled $1.18bn in Q1 2021. With a 53.11% share and deals worth $626.67m, the US was the top country in North America’s cross border venture financing deal value across medical devices industry.

In terms of deal activity, North America recorded 31 cross border deals during Q1 2021, marking an increase of 10.71% over the previous quarter and a rise of 30.53% over the last four-quarter average. The US recorded 25 deals during the month.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

North America medical devices industry cross border venture financing deals in Q1 2021: Top deals

The top five cross border venture financing deals accounted for 49.6% of the overall value during Q1 2021.

The combined value of the top five medical devices cross border venture financing deals stood at $355m, against the overall value of $715.46m recorded for the quarter.

The top five medical devices cross border deals of Q1 2021 tracked by GlobalData were:

1) Altium Capital, Axiom Associates, Colle Capital Partners, GV Management Co, Huamin Investment Management and Nextrans’ $90m venture financing of Hyperfine Research

2) The $82m venture financing of Scipher Medicine by Alumni Ventures Group, aMoon Partners, Echo Health Ventures, Khosla Ventures and Northpond Ventures

3) Ally Bridge Group and Northpond Ventures’ $68m venture financing of Syapse

4) The $65m venture financing of CorVista Health by Ambix Life Science Fund I and MedVenture Partners

5) HBM Partners, Khosla Ventures, Provenio Capital, Redmile Group, Samsara BioCapital and Verily Life Sciences’ venture financing of Genalyte for $50m.